guaiacol has been researched along with beta-lactams in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bright, SA; Carr, M; Carroll, P; Conneally, E; Croke, A; Fayne, D; Gagliardi, M; Greene, LM; Keely, NO; Lawler, M; Lloyd, DG; McElligott, AM; Meegan, MJ; Nathwani, SM; O'Boyle, NM; O'Connor, L; Sarkadi, B; Zisterer, DM | 1 |
| Carr, M; Greene, LM; Hughes, L; McDonnell, S; Meegan, MJ; Nathwani, SM; O'Boyle, NM; Zisterer, DM | 1 |
2 other study(ies) available for guaiacol and beta-lactams
| Article | Year |
|---|---|
The vascular targeting agent combretastatin-A4 and a novel cis-Restricted {beta}-Lactam Analogue, CA-432, induce apoptosis in human chronic myeloid leukemia cells and ex vivo patient samples including those displaying multidrug resistance.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Azetidines; beta-Lactams; Blotting, Western; Cell Cycle; Cell Proliferation; Cell Survival; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Guaiacol; HL-60 Cells; Humans; K562 Cells; Microscopy, Confocal; Microscopy, Fluorescence; Microtubules; Molecular Structure; Stereoisomerism; Stilbenes; Tubulin | 2010 |
Novel cis-restricted β-lactam combretastatin A-4 analogues display anti-vascular and anti-metastatic properties in vitro.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Azetidines; beta-Lactams; Breast Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Survival; G2 Phase Cell Cycle Checkpoints; Guaiacol; Human Umbilical Vein Endothelial Cells; Humans; Microtubules; Vascular Endothelial Growth Factor A | 2013 |